Novartis Investigative Site

Edirne 22030

0 studies enrolling now · 4 studies all time

What they study most

Advanced Metastatic Breast Cancer, Anaplastic Thyroid Cancer, Heart Failure With Reduced Ejection Fraction, Immune Thrombocytopenic Purpura (ITP), Melanoma, Non-small Sell Lung Cancer (NSCLC), Other Solid Tumors, Triple Negative Breast Cancer

Studies at this site

• A Study to Assess the Ability of Eltrombopag to Induce Sustained Response Off Treatment in Subjects With ITP — Completed
• Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer — Completed
• Phase I/II Study of PDR001 in Patients With Advanced Malignancies — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early